Skip to content

Effect of Virtual Reality Training on Pain, Functional Disability, and Lumbar Reposition Error in Patients With Chronic Non-Specific Low Back Pain

Effect of Virtual Reality Training on Pain, Functional Disability, and Lumbar Reposition Error in Patients With Chronic Non-Specific Low Back Pain: A Randomized Control Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07577778
Enrollment
50
Registered
2026-05-11
Start date
2025-09-03
Completion date
2026-04-30
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Specific Chronic Low Back Pain

Brief summary

This study aims to investigate the effect of virtual reality (VR) training on pain intensity, functional disability, and lumbar reposition error in patients with chronic non-specific low back pain.

Detailed description

This randomized controlled trial was conducted to evaluate the effectiveness of virtual reality (VR) training in patients with chronic non-specific low back pain (CNSLBP). Chronic low back pain is a highly prevalent condition associated with impaired proprioception, altered motor control, and functional disability. Fifty participants diagnosed with CNSLBP were randomly assigned into two groups. The intervention group received virtual reality-based training in addition to conventional physiotherapy, while the control group received conventional treatment alone. Outcome measures included pain intensity assessed by the Visual Analogue Scale (VAS), functional disability assessed by the Oswestry Disability Index (ODI), and lumbar repositioning error measured using an iPhone inclinometer application. The study aimed to determine whether VR training could significantly improve pain, functional outcomes, and proprioceptive accuracy in this population.

Interventions

DEVICETranscutaneous Electrical Nerve Stimulation (TENS)

TENS was applied in a prone position with electrodes placed over the painful area. Low-frequency stimulation (2-10 Hz) was used to achieve analgesic effects. Intensity was adjusted to produce a strong but comfortable tingling sensation. Each session lasted 20-60 minutes.

DRUGTherapeutic Ultrasound

Ultrasound therapy was applied using appropriate frequency (1 MHz for deep tissues, 3 MHz for superficial tissues) and intensity (0.5-2.0 W/cm²). Continuous or pulsed modes were selected based on the condition. Each session lasted 5-10 minutes.

Participants performed trunk stabilization exercises including supine bridge, supine bridge on Swiss ball, and prone plank. Each exercise was performed for 30 seconds with 30 seconds rest, repeated 5 times, 3 sets per session, 3 times per week.

Participants underwent VR training using Xbox 360 Kinect system. The setup included a motion sensor and projector, allowing full-body interaction through game-based activities. Training consisted of interactive games (e.g., rafting, running, ball hitting) designed to improve trunk control and motor function. Sessions were conducted twice weekly for 30 minutes over 12 weeks. Exercises included movements such as jumping, trunk tilting, and arm coordination, with progressive difficulty levels.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Patients with low back pain ≥ 12 weeks Age: 21-45 years Both genders BMI: 18.5-24.9

Exclusion criteria

* iabetic neuropathy Sciatica Spine deformities Previous lumbar surgery Neurological or vestibular disorders Visual disorders Malignancy or trauma Structural spinal disorders (stenosis, osteoporosis, etc.)

Design outcomes

Primary

MeasureTime frame
Pain intensity (VAS)1 Month
Functional disability (Oswestry Disability Index)1 Month
Lumbar reposition error (iPhone inclinometer)1 Month

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026